The International Registry of Coronavirus Exposure in Pregnancy (IRCEP) is a prospective cohort study of pregnant and recently pregnant women who have been tested for SARS-CoV-2 (regardless of the result) or have been clinically diagnosed with COVID-19 by a health care professional. Data from the IRCEP will be used to evaluate the impact of COVID-19 on pregnancy and birth outcomes.
The International Registry of Coronavirus Exposure in Pregnancy (IRCEP) will enroll women 18
years of age and older who are currently pregnant or have been pregnant women within the last
6 months, and who have been tested for SARS-CoV-2 (regardless of the result) or have been
clinically diagnosed with COVID-19 by a health care professional. As this is an international
registry, women from all countries are welcome to participate.
Women will enroll and provide information to the IRCEP via website and mobile app. After
signing the electronic informed consent document, registrants will answer questions on the
following modules: Demographics, Reproductive History, Height and Weight, Habits, Health
Conditions, Medications, Current Pregnancy, COVID-19 Infection Test, and COVID-19 Infection
Symptoms. Monthly follow-up modules will continue until the pregnancy outcome. In case of a
live birth, the Registry participant will continue with the Post-Partum Outcomes module until
the newborn is 90 days of age. Medical records from the mother and neonate will also be
requested.
Other: Tested for SARS-CoV-2 (regardless of the result)
This is an observational study with no intervention
Other: Clinical diagnosis of COVID-19 by a health care professional
This is an observational study with no intervention
Inclusion Criteria:
- Pregnant women or women who have been pregnant within the last 6 months
- Able to give electronic informed consent
- Tested for SARS-CoV-2 (regardless of the result) or clinically diagnosed with COVID-19
by a health care professional
Exclusion Criteria:
- <18 years of age
Pregistry
Los Angeles, California, United States
Diego Wyszynski, MD, MHS, PhD, Principal Investigator
CEO Pregistry